Medical Beauty · Diagnostic
Japanese Patient Acquisition, diagnose before entering the competition
Market growth does not establish provider-level profitability. RIVACTA's Medical Beauty Diagnostic evaluates Japanese-language consultation, booking, aftercare, regulatory readiness, and contribution-margin conditions.
The real challenge
Why Japanese patient acquisition is hard
Without validating clinical fit, consultation, and aftercare capacity, price competition and referral-only acquisition make profitability difficult to assess.
Contracts are being considered before the applicable referral-fee limits and client-side review owner are confirmed.
Marketing execution is delayed because regulatory readiness — medical ad pre-review, Medical Care Act, privacy requirements — isn't in place.
RIVACTA's approach
Diagnose regulation and differentiation before executing
RIVACTA's Medical Beauty Diagnostic organizes evidence for demand, contract structure, regulatory dependencies, operational readiness, and differentiation. Regulatory judgments remain with the client's responsible owner or designated specialist.
- Japanese patient segment analysis using search, inquiry, booking data, and official sources
- Evidence for referral-fee and contract structures, plus the client-side review owner
- Applicable medical-advertising and privacy requirements, with designated-specialist review status
- Differentiation points and channel priorities in an oversupplied market
Market evidence data
Start with a 30-minute Fit Call
This 30-minute pre-contract Fit Call has no deliverable. Work begins only after the paid Market Diagnostic is contracted.
Request a Fit CallThe 30-minute Fit Call is pre-contract and has no deliverable